Just out: our overview of over two decades of the use of TRIPS flexibilities to access medicines in BMJ Global Health gh.bmj.com/content/11/1...
gh.bmj.com
Introduction Millions of people lack access to safe and effective pharmaceuticals because they are unaffordable or unavailable, particularly in ‘developing’ and ‘least-developed’ countries (DCs, LDCs)...